Edap Tms (NASDAQ:EDAP) Downgraded by StockNews.com to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday.

Separately, HC Wainwright reiterated a “buy” rating and issued a $19.00 price target on shares of Edap Tms in a report on Thursday, August 29th.

Edap Tms Trading Up 1.7 %

EDAP opened at $2.41 on Tuesday. The stock has a market cap of $89.41 million, a price-to-earnings ratio of -3.65 and a beta of 0.38. The stock’s 50 day moving average price is $2.69 and its 200-day moving average price is $4.08. Edap Tms has a one year low of $2.27 and a one year high of $8.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). The business had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, equities analysts forecast that Edap Tms will post -0.6 EPS for the current year.

Institutional Trading of Edap Tms

A number of large investors have recently modified their holdings of the company. Virtu Financial LLC purchased a new stake in Edap Tms during the first quarter worth $82,000. Commonwealth Equity Services LLC lifted its holdings in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after buying an additional 4,000 shares during the period. Redhawk Wealth Advisors Inc. purchased a new stake in Edap Tms during the third quarter worth $36,000. BNP Paribas Financial Markets lifted its holdings in Edap Tms by 23.7% during the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares during the period. Finally, Parkman Healthcare Partners LLC purchased a new stake in Edap Tms during the third quarter worth $395,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.